Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Prevention of Metabolic Syndrome by Telephone-Delivered Lifestyle Intervention in a Real-World Setting: Sub-Analysis of a Cluster-Randomized Trial.

Sakane N, Kotani K, Suganuma A, Takahashi K, Sato J, Suzuki S, Izumi K, Kato M, Noda M, Nirengi S, Kuzuya H.

Metab Syndr Relat Disord. 2019 May 30. doi: 10.1089/met.2018.0130. [Epub ahead of print]

PMID:
31145031
2.

Maslinic acid derived from olive fruit in combination with resistance training improves muscle mass and mobility functions in the elderly.

Nagai N, Yagyu S, Hata A, Nirengi S, Kotani K, Moritani T, Sakane N.

J Clin Biochem Nutr. 2019 May;64(3):224-230. doi: 10.3164/jcbn.18-104. Epub 2019 Mar 7.

3.

Applicability of Supraclavicular Oxygenated and Total Hemoglobin Evaluated by Near-Infrared Time-Resolved Spectroscopy as Indicators of Brown Adipose Tissue Density in Humans.

Nirengi S, Fuse S, Amagasa S, Homma T, Kime R, Kuroiwa M, Endo T, Sakane N, Matsushita M, Saito M, Kurosawa Y, Hamaoka T.

Int J Mol Sci. 2019 May 6;20(9). pii: E2214. doi: 10.3390/ijms20092214.

4.

Partial Range of Motion Exercise Is Effective for Facilitating Muscle Hypertrophy and Function Through Sustained Intramuscular Hypoxia in Young Trained Men.

Goto M, Maeda C, Hirayama T, Terada S, Nirengi S, Kurosawa Y, Nagano A, Hamaoka T.

J Strength Cond Res. 2019 May;33(5):1286-1294. doi: 10.1519/JSC.0000000000002051.

PMID:
31034463
5.

Pretreatment Blood Pressure is a Simple Predictor of Hemorrhagic Infarction after Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) Therapy.

Ohtani R, Nakamura M, Nirengi S, Kawakami O, Togawa J, Doi K, Sainouchi M, Kuwata Y, Takata M, Masuda Y, Matsunari R, Takeda K, Tsukahara T, Sakane N.

J Stroke Cerebrovasc Dis. 2019 Jul;28(7):1979-1986. doi: 10.1016/j.jstrokecerebrovasdis.2019.03.035. Epub 2019 Apr 11.

PMID:
30982718
6.

Prevalence and Risk Factors of Elevated Liver Enzymes in Japanese Women With Polycystic Ovary Syndrome.

Minato S, Sakane N, Kotani K, Nirengi S, Hayashi I, Suganuma A, Yamaguchi K, Takakura K, Nagai N.

J Clin Med Res. 2018 Dec;10(12):904-910. doi: 10.14740/jocmr3639. Epub 2018 Oct 30.

7.

High-Density Lipoprotein Subclasses and Mild Cognitive Impairment: Study of Outcome and aPolipoproteins in Dementia (STOP-Dementia)1.

Ohtani R, Nirengi S, Nakamura M, Murase N, Sainouchi M, Kuwata Y, Takata M, Masuda Y, Kotani K, Sakane N.

J Alzheimers Dis. 2018;66(1):289-296. doi: 10.3233/JAD-180135.

PMID:
30248050
8.

Nonalcoholic Fatty Liver Disease in University Rugby Football Players.

Nirengi S, Fujibayashi M, Furuno S, Uchibe A, Kawase Y, Sukino S, Kawaguchi Y, Minato S, Kotani K, Sakane N.

Front Endocrinol (Lausanne). 2018 Jun 20;9:341. doi: 10.3389/fendo.2018.00341. eCollection 2018.

9.

Brown adipose tissue density measured by near-infrared time-resolved spectroscopy in Japanese, across a wide age range.

Fuse S, Nirengi S, Amagasa S, Homma T, Kime R, Endo T, Sakane N, Matsushita M, Saito M, Yoneshiro T, Kurosawa Y, Hamaoka T.

J Biomed Opt. 2018 Jun;23(6):1-9. doi: 10.1117/1.JBO.23.6.065002.

PMID:
29900702
10.

Effects of a Low Advanced Glycation End Products Diet on Insulin Levels: The Feasibility of a Crossover Comparison Test.

Sukino S, Nirengi S, Kawaguchi Y, Kotani K, Tsuzaki K, Okada H, Suganuma A, Sakane N.

J Clin Med Res. 2018 May;10(5):405-410. doi: 10.14740/jocmr3301w. Epub 2018 Mar 16.

11.

Seasonal differences in brown adipose tissue density and pulse rate variability in a thermoneutral environment.

Nirengi S, Sakane N, Amagasa S, Wakui S, Homma T, Kurosawa Y, Hamaoka T.

J Physiol Anthropol. 2018 Feb 21;37(1):6. doi: 10.1186/s40101-018-0166-x.

12.

Safety of the batteries and power units used in insulin pumps: A pilot cross-sectional study by the Association for the Study of Innovative Diabetes Treatment in Japan.

Murata T, Nirengi S, Sakane N, Kuroda A, Hirota Y, Matsuhisa M, Namba M, Kobayashi T; Association for the Study of Innovative Diabetes Treatment in Japan (ASINDTJ).

J Diabetes Investig. 2018 Jul;9(4):903-907. doi: 10.1111/jdi.12765. Epub 2017 Nov 28.

13.

Determinants of Glycated Hemoglobin in Subjects With Impaired Glucose Tolerance: Subanalysis of the Japan Diabetes Prevention Program.

Sakane N, Sato J, Tsushita K, Tsujii S, Kotani K, Tominaga M, Kawazu S, Sato Y, Usui T, Kamae I, Yoshida T, Kiyohara Y, Sato S, Tsuzaki K, Nirengi S, Takahashi K, Kuzuya H, Group JR.

J Clin Med Res. 2017 Apr;9(4):360-365. doi: 10.14740/jocmr2928w. Epub 2017 Feb 21.

14.
15.

Diagnostic accuracy of the anti-glutamic acid decarboxylase antibody in type 1 diabetes mellitus: Comparison between radioimmunoassay and enzyme-linked immunosorbent assay.

Murata T, Tsuzaki K, Nirengi S, Watanabe T, Mizutani Y, Okada H, Tsukamoto M, Odori S, Nakagawachi R, Kawaguchi Y, Yoshioka F, Yamada K, Shimatsu A, Kotani K, Satoh-Asahara N, Sakane N.

J Diabetes Investig. 2017 Jul;8(4):475-479. doi: 10.1111/jdi.12594. Epub 2017 Jan 6.

16.

Daily ingestion of catechin-rich beverage increases brown adipose tissue density and decreases extramyocellular lipids in healthy young women.

Nirengi S, Amagasa S, Homma T, Yoneshiro T, Matsumiya S, Kurosawa Y, Sakane N, Ebi K, Saito M, Hamaoka T.

Springerplus. 2016 Aug 18;5(1):1363. doi: 10.1186/s40064-016-3029-0. eCollection 2016.

17.

Assessment of human brown adipose tissue density during daily ingestion of thermogenic capsinoids using near-infrared time-resolved spectroscopy.

Nirengi S, Homma T, Inoue N, Sato H, Yoneshiro T, Matsushita M, Kameya T, Sugie H, Tsuzaki K, Saito M, Sakane N, Kurosawa Y, Hamaoka T.

J Biomed Opt. 2016 Sep;21(9):091305. doi: 10.1117/1.JBO.21.9.091305.

PMID:
27135066
18.

ACTN3 GENE R577X POLYMORPHISM ASSOCIATED WITH HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND ADIPONECTIN IN RUGBY PLAYERS.

Nirengi S, Fujibayashi M, Tsuzaki K, Furuno S, Uchibe A, Kawase Y, Kotani K, Sakane N.

Endocr Pract. 2016 Jul;22(7):786-90. doi: 10.4158/EP15963.OR. Epub 2016 Feb 26.

PMID:
26919654
19.

Evaluation of Brown Adipose Tissue Using Near-Infrared Time-Resolved Spectroscopy.

Nirengi S, Yoneshiro T, Saiki T, Aita S, Matsushita M, Sugie H, Saito M, Hamaoka T.

Adv Exp Med Biol. 2016;876:371-376. doi: 10.1007/978-1-4939-3023-4_46.

PMID:
26782234
20.

A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles.

Kurosawa Y, Nirengi S, Homma T, Esaki K, Ohta M, Clark JF, Hamaoka T.

Sci Rep. 2015 Jun 25;5:11601. doi: 10.1038/srep11601.

Supplemental Content

Loading ...
Support Center